Healthcare provider profile · identity verified

Brian A Lindo, MD

Family Practice · CEDAR RAPIDS, IA · NPI 1871571273

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	807	222
Levothyroxine Sodium	Levothyroxine Sodium	385	93
Metoprolol Succinate	Metoprolol Succinate	332	92
Lisinopril	Lisinopril	320	93
Hydrochlorothiazide	Hydrochlorothiazide	272	70
Pantoprazole Sodium	Pantoprazole Sodium	235	65
Amlodipine Besylate	Amlodipine Besylate	207	64
Tamsulosin Hcl	Tamsulosin Hcl	175	48
Metformin Hcl	Metformin Hcl	170	46
Omeprazole	Omeprazole	162	53
Rosuvastatin Calcium	Rosuvastatin Calcium	157	47
Losartan Potassium	Losartan Potassium	152	38
Gabapentin	Gabapentin	134	47
Nifedipine Er	Nifedipine	133	43
Allopurinol	Allopurinol	127	33
Escitalopram Oxalate	Escitalopram Oxalate	119	32
Furosemide	Furosemide	109	38
Irbesartan	Irbesartan	109	35
Trazodone Hcl	Trazodone Hcl	98	29
Ozempic	Semaglutide	96	19
Montelukast Sodium	Montelukast Sodium	95	28
Albuterol Sulfate Hfa	Albuterol Sulfate	94	40
Metformin Hcl Er	Metformin Hcl	79	24
Zolpidem Tartrate	Zolpidem Tartrate	77	22
Buspirone Hcl	Buspirone Hcl	75	23
Simvastatin	Simvastatin	75	26
Alendronate Sodium	Alendronate Sodium	74	27
Duloxetine Hcl	Duloxetine Hcl	73	29
Prednisone	Prednisone	71	46
Metoprolol Tartrate	Metoprolol Tartrate	69	16
Fenofibrate	Fenofibrate	66	15
Alprazolam	Alprazolam	62	22
Fluoxetine Hcl	Fluoxetine Hcl	61	14
Sertraline Hcl	Sertraline Hcl	61	23
Xarelto	Rivaroxaban	60	suppressed
Clopidogrel	Clopidogrel Bisulfate	59	13
Tramadol Hcl	Tramadol Hcl	59	27
Pravastatin Sodium	Pravastatin Sodium	55	15
Bupropion Xl	Bupropion Hcl	54	18
Oxybutynin Chloride	Oxybutynin Chloride	53	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	15
Spironolactone	Spironolactone	52	14
Farxiga	Dapagliflozin Propanediol	51	suppressed
Citalopram Hbr	Citalopram Hydrobromide	50	14
Nabumetone	Nabumetone	49	26
Diclofenac Sodium	Diclofenac Sodium	47	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	14
Meloxicam	Meloxicam	47	20
Sulindac	Sulindac	47	27
Eliquis	Apixaban	46	14
Glipizide Er	Glipizide	45	13
Finasteride	Finasteride	44	11
Hydroxyzine Hcl	Hydroxyzine Hcl	41	12
Mirtazapine	Mirtazapine	39	suppressed
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	11
Gemfibrozil	Gemfibrozil	34	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	34	suppressed
Benazepril Hcl	Benazepril Hcl	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Jardiance	Empagliflozin	33	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	32	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	13
Synthroid	Levothyroxine Sodium	29	suppressed
Methocarbamol	Methocarbamol	28	13
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Atenolol	Atenolol	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Valacyclovir	Valacyclovir Hcl	26	12
Arnuity Ellipta	Fluticasone Furoate	24	suppressed
Carvedilol	Carvedilol	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	14
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Propranolol Hcl Er	Propranolol Hcl	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Lorazepam	Lorazepam	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Cephalexin	Cephalexin	18	16
Donepezil Hcl	Donepezil Hcl	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Potassium Chloride	Potassium Chloride	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Famotidine	Famotidine	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Cefadroxil	Cefadroxil	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Cefuroxime	Cefuroxime Axetil	12	12
Dilantin	Phenytoin Sodium Extended	12	suppressed
Estradiol	Estradiol	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Levetiracetam	Levetiracetam	11	suppressed
Roflumilast	Roflumilast	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error